IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review)

International Journal of Oncology · Published 2026-02-20 · DOI 10.3892/ijo.2026.5860

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.3892/ijo.2026.5860

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles